Rapid assessment and response to injecting drug use in Madras, south India

International Journal of Drug Policy

Volumn 11, Issue 1-2, 2000, Pages 83-98

  Kumar, M Suresh ^a,b,c   Mudaliar, Shakuntala ^a,b   Thyagarajan, S P ^d   Kumar, Senthil ^a,c   Selvanayagam, Arun ^a,c   Daniels, Desmond ^a  

^a SAHAI Trust   (India)

^b Punarjeevan Drug Treatment Centre   (India)

^c Institute of Mental Health   (India)

^d Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

HIV prevention; India; Injecting drug use; Rapid assessment

Indexed keywords

BUPRENORPHINE; CHLORPHENIRAMINE MALEATE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; DRUG; MORPHINE; PENTAZOCINE; PETHIDINE; PROMETHAZINE; PROXYVAN; TIDIGESIC; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; DRUG ABUSE; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INJECTION; LOWEST INCOME GROUP; MALE; PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

EID: 0034161374     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(99)00057-2     Document Type: Article

References (47)

1. Ahmed S.K., Ara N. Patterns and trends of Buprenorphine abuse - an ethnographic study. Navaratnam V., Vemala D. International Monograph Series 10. 1997;1-29 Centre for Drug Research USM, Pulau Penang.
2. Anthony C, Paul R, Kumar SM. A perspective from India: Madras. In: Machado T, Jaiprakash I, editors. Cultural strategies for drug abuse intervention programs in Asian settings - International series - 4. Paris: International Federation of Catholic Universities, 1994; 83-106.
3. Ball A. Overview: Policies and interventions to stem HIV-1 epidemics associated with injecting drug use. Stimson G.V., Des Jarlais D., Ball A. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. 1998;University College London Press, London.
4. Ball A., Rana S., Dehne K.L. HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Reports. 113(Supplement 1):1998;170-181.
5. Basu D., Mattoo S.K., Arora A., Malhotra A., Varma V.K. Pseudoaneurysm in injecting drug users: Cases from India. Addiction. 89:1994;1697-1699.
6. Chowdhuri A.N., Chowdhuri S. Buprenorphine abuse: a report from India. British Journal of Addiction. 85:1990;1349-1350.
7. Chowdhury M.R., Islam M.N., Rasul M.G. Risk behaviour amongst drug abusers in the spread of HIV in Bangladesh. Navaratnam V., Abu Baker A. International Monograph Series 12. 1998;1-7 Centre for Drug Research USM, Pulau Penang.
8. Crofts N., Reid G., Deany P. Injecting drug use and HIV infection in Asia. AIDS. 12(Supplement B):1998;S69-S78.
9. Crofts N., Costigan G., Narayanan P. et al. Harm reduction in Asia: A successful response to hidden epidemics. AIDS. 12(Supplement B):1998;S109-S115.
10. Des Jarlais D.C., Choopanya K., Millson P., Friedman P., Friedman S.R. The structure of stable seroprevalence HIV-1 epidemics among injecting drug users. Stimson G.V., Des Jarlais D., Ball A. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. 1998;University College London Press, London.
11. Dorabjee J.D., Samson L.J. Self and community based opioid substitution among opioid dependent populations in the Indian sub-continent. International Journal of Drug Policy. 9:1998;411-416.
12. Dorabjee J.D., Samson L.J. A multi-centre rapid assessment of injecting drug use in India. International Journal of Drug Policy. 11:2000;99-112.
13. Fisher D.G., Needle R. AIDS and Community-Based Drug Intervention Programs. 1993;Harrington Press, New York.
14. Hangzo C., Chatterjee A., Sarkar S. et al. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Addiction. 92:1997;813-820.
15. Joseph R. HIV risk behaviour and risk reduction among injecting drug users in treatment (dissertation). Madras: Dr. MGR Medical University, 1996.
16. Karki BB, Upreti S. RAR Survey among drug users in Nepal, January 1999. Paper presented at the Intercountry Technical Workshop for the Prevention of Drug Use and HIV/AIDS organised by UNAIDS/ESCAP, New Delhi, 1999, June 1-4.
17. Kellam S.G., Branch J.D. An approach to community mental health: Analysis of basic problems. Seminars in Psychiatry. 3:1971;207-225.
18. Kumar S.M. A study of factors contributing to relapse in alcohol/drug dependents. Navaratnam V., Abu Baker A. International Monograph Series 12. 1998;16-20 Centre for Drug Research USM, Pulau Penang.
19. Kumar S.M., Daniels D. HIV Risk Reduction Strategies among IDUs in Madras. 1994;CARITAS, New Delhi.
20. Kumar SM, Daniels D. HIV intervention strategies among injecting drug users in Madras City, India: What works? Third Science Forum: HIV Prevention Research: Current Status and Future Directions. Northern Arizona University, Flagstaff, AZ, 1995 Aug 16-18.
21. Kumar S.M., Mudaliar S. Comparative analysis of HIV sexual and substance use risk behaviours among injecting heroin users and buprenorphine users in a drug treatment program. Navaratnam V., Vemala D. International Monograph Series 10. 1997;70-78 Centre for Drug Research USM, Pulau Penang.
22. Kumar SM, Mandell W, Shakuntala, Daniels D. Buprenorphine dependence among injecting drug users in Madras City, India. In: Abstracts of the 57th Annual Scientific Meeting, College on Problems of Drug Dependence, 1995;80.
23. Kumar SM, Mudaliar S, Daniels D. Community-based HIV interventions for street-recruited drug users at Madras, India. Fourth Science Forum: Research Synthesis Symposium on the Prevention of HIV in Drug Abusers. Northern Arizona University, Flagstaff, AZ, 1997, Aug 3-5.
24. Kumar S.M., Mudaliar S., Daniels D. Community based outreach HIV intervention for street-recruited drug users in Madras, India. Public Health Reports. 113(Supplement 1):1998;58-66.
25. Lal R. Buprenorphine dependence - analysis of seven cases. Indian Journal of Psychiatry. 33:1991;62-65.
26. Latkin C., Mandell W., Oziemkowska M., Vlahov D., Celentano D. The relationships between sexual behaviour, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sexually Transmitted Diseases. 21:1994;161-167.
27. Latkin C., Mandell W.D., Vlahov D. et al. My place, your place and no place: behaviour settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. American Journal of Community Psychology. 22:1994;415-431.
28. Ling W, Shoptaw S. Introduction of Research in Pharmacotherapy for Addictive Disease: Where are we? Where are we going? In: The Integration of Pharmacological and Nonpharmacological treatment in Drug and Alcohol Addictions editors. Miller NS, Stimmel D. The Haworth Medical Press, an imprint of The Howarth Press Inc., 1997; 83-102.
29. Ling W., Wesson D.R., Charuvasta C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry. 53:1996;401-407.
30. NACO Country Scenario 1997-98. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 1999.
31. Naik T.N., Sarkar S., Singh H.L., Bhunia S.C., Singh Y.I., Singh P.K., Pal S.C. Intravenous drug users: a new high-risk group for HIV infection in India. AIDS. 5:1991;117-118.
32. Panda S., Chatterjee A., Sarkar S. et al. Injecting drug use in Calcutta: A potential focus for an explosive HIV epidemic. Drug and Alcohol Review. 16:1997;17-23.
33. Peak A., Rana S., Maharjan S.H., Jolley D., Crofts N. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm reduction programme. AIDS. 9:1995;1067-1070.
34. Rhodes T., Hartnoll G.M. AIDS, Drugs and Prevention: Perspectives on Individual and Community Action. 1996;Routledge, London.
35. Rhodes T., Stimson G.V., Quirk A. Sex, drugs, intervention and research: from the individual to the social. Substance Use and Misuse. 31:1996;375-407.
36. Rhodes T., Stimson G.V., Crofts N., Ball A., Dehne K., Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS. 13(Supplement A):1999;S259-S269.
37. Rhodes T., Stimson G.V., Fitch C., Ball A., Renton A. Rapid assessment, injecting drug use, and public health. Lancet. 354:1999;65-68.
38. Sarkar S., Mookerjee P., Roy A. et al. Descriptive epidemiology of intravenous heroin users - a new risk group for transmission of HIV in India. Journal of Infection. 23:1991;201-207.
39. Sarkar S., Das N., Panda S. et al. Rapid spread of HIV among injecting drug users in north-eastern states of India. Bulletin of Narcotics. XLV(1):1994;91-105.
40. Singh M. Making target communities and workplaces drug free in India. Navaratnam V., Abu Baker A. International Monograph Series 12. 1998;21-29 Centre for Drug Research USM, Pulau Penang.
41. Singh R.A., Mattoo S.K., Malhotra A. et al. Cases of buprenorphine abuse in India. Acta Psychiatrica Scandinavica. 86:1992;46-48.
42. Stimson G.V. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bulletin of Narcotics. XLV(1):1993;3-17.
43. Stimson G.V., Choopanya Global perspectives on drug injecting. Stimson G.V., Des Jarlais D.C., Ball A. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. 1998;University College London Press, London.
44. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Comparison of buprenorphine to methadone in the treatment of opioid dependence. American Journal of Psychiatry. 151:1994;1025-1030.
45. Strang J., Stimson G.V., Des Jarlais D.C. Editorial: What is AIDS doing to the drug research agenda? British Journal of Addiction. 87:1992;343-346.
46. Vicknasingam B. An exploratory study of Intravenous drug use behaviour and HIV/AIDS knowledge. Navaratnam V., Abu Baker A. International Monograph Series 12. 1998;32-38 Centre for Drug Research USM, Pulau Penang.
47. World Health Organization, 1998. Programme on substance abuse: the rapid assessment and response guide on injecting drug use (draft for field testing). Geneva: WHO, 1998.